Cooper Companies, Inc. (The) (NYSE:COO) had its price objective boosted by stock analysts at Stifel Nicolaus from $265.00 to $275.00 in a note issued to investors on Tuesday. The firm presently has a “buy” rating on the medical device company’s stock. Stifel Nicolaus’ price objective would suggest a potential upside of 11.52% from the stock’s current price.

A number of other analysts also recently issued reports on the stock. Zacks Investment Research upgraded shares of Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $270.00 price target on the stock in a report on Friday, September 8th. Robert W. Baird reiterated a “buy” rating and issued a $267.00 price target (up from $251.00) on shares of Cooper Companies, Inc. (The) in a report on Sunday, September 3rd. BMO Capital Markets reiterated a “buy” rating and issued a $272.00 price target on shares of Cooper Companies, Inc. (The) in a report on Friday, September 1st. Piper Jaffray Companies lifted their price target on shares of Cooper Companies, Inc. (The) from $265.00 to $280.00 and gave the company an “overweight” rating in a report on Friday, September 1st. Finally, KeyCorp reiterated a “hold” rating on shares of Cooper Companies, Inc. (The) in a report on Monday, August 28th. Six analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $257.60.

Shares of Cooper Companies, Inc. (NYSE:COO) opened at 246.60 on Tuesday. Cooper Companies, Inc. has a 52-week low of $158.73 and a 52-week high of $256.39. The stock has a market capitalization of $12.05 billion, a price-to-earnings ratio of 36.97 and a beta of 0.59. The firm’s 50-day moving average is $245.39 and its 200 day moving average is $223.93.

Cooper Companies, Inc. (The) (NYSE:COO) last announced its quarterly earnings results on Thursday, August 31st. The medical device company reported $2.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.58 by $0.06. The company had revenue of $556.00 million for the quarter, compared to the consensus estimate of $552.32 million. Cooper Companies, Inc. (The) had a net margin of 16.45% and a return on equity of 16.00%. Cooper Companies, Inc. (The)’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.30 EPS. Equities analysts expect that Cooper Companies, Inc. will post $9.72 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The original version of this news story can be accessed at https://www.dailypolitical.com/2017/09/14/cooper-companies-inc-the-coo-pt-raised-to-275-00.html.

In other news, CEO Paul L. Remmell sold 9,294 shares of the stock in a transaction dated Friday, July 14th. The shares were sold at an average price of $248.46, for a total value of $2,309,187.24. Following the completion of the sale, the chief executive officer now directly owns 6,186 shares in the company, valued at $1,536,973.56. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO Daniel G. Mcbride sold 6,000 shares of the stock in a transaction dated Wednesday, June 21st. The shares were sold at an average price of $244.23, for a total transaction of $1,465,380.00. Following the completion of the sale, the chief operating officer now owns 34,395 shares of the company’s stock, valued at $8,400,290.85. The disclosure for this sale can be found here. Insiders sold 17,015 shares of company stock valued at $4,193,502 over the last quarter. Company insiders own 1.60% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of COO. Capstone Asset Management Co. acquired a new stake in shares of Cooper Companies, Inc. (The) in the first quarter valued at about $269,000. Profund Advisors LLC raised its position in shares of Cooper Companies, Inc. (The) by 9.1% in the first quarter. Profund Advisors LLC now owns 2,059 shares of the medical device company’s stock valued at $412,000 after buying an additional 171 shares during the last quarter. ProShare Advisors LLC raised its position in shares of Cooper Companies, Inc. (The) by 1.5% in the first quarter. ProShare Advisors LLC now owns 4,896 shares of the medical device company’s stock valued at $979,000 after buying an additional 73 shares during the last quarter. Wells Fargo & Company MN raised its position in shares of Cooper Companies, Inc. (The) by 33.7% in the first quarter. Wells Fargo & Company MN now owns 152,303 shares of the medical device company’s stock valued at $30,443,000 after buying an additional 38,379 shares during the last quarter. Finally, Commerzbank Aktiengesellschaft FI acquired a new stake in shares of Cooper Companies, Inc. (The) in the first quarter valued at about $237,000. Institutional investors and hedge funds own 95.92% of the company’s stock.

Cooper Companies, Inc. (The) Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Analyst Recommendations for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with MarketBeat.com's FREE daily email newsletter.